FOXP3 and autoimmune disease: A partial reduction in FOXP3 levels is assumed to be beneficial to patient safety, especially when considering the link between loss-of-function mutations in FOXP3 and autoimmune disorders in humans, the most extreme of which is the very rare immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (18).